Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model

BACKGROUND: Allergen‐specific immunotherapy can induce long‐term suppression of allergic symptoms, reduce medication use, and prevent exacerbations of allergic rhinitis and asthma. Current treatment is based on crude allergen extracts, which contain immunostimulatory components such as β‐glucans, ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Hesse, L., van Ieperen, N., Habraken, C., Petersen, A. H., Korn, S., Smilda, T., Goedewaagen, B., Ruiters, M. H., van der Graaf, A. C., Nawijn, M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947840/
https://www.ncbi.nlm.nih.gov/pubmed/29318623
http://dx.doi.org/10.1111/all.13382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947840/
https://www.ncbi.nlm.nih.gov/pubmed/29318623
http://dx.doi.org/10.1111/all.13382

Ejemplares similares